Delivery Order SPE2DE24D0013-SPE2D626F105G
- Not listed
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $17,162.40 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025. This delivery order, designated XPRSMVP-10, is set to be completed by October 27, 2025, and represents an order for molecular diagnostic reagents and test kits designed for the GeneXpert diagnostic platform. The work will be performed at Cepheid's facility in Sunnyvale, California. This award reflects...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $13,709.36 by the Defense Logistics Agency Medical Supply Chain on November 13, 2025, with an ultimate completion date of November 20, 2025. This firm fixed-price delivery order, identified as XPRSMVP-10, carries no set-aside designation and represents a continuation of Cepheid's substantial role as a primary federal supplier of diagnostic solutions. The...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,040 on October 28, 2025, by the Defense Logistics Agency Medical Supply Chain, with an ultimate completion date of November 4, 2025. This firm fixed-price delivery order, designated as XPRS4PLEX-10, carries no set-aside designation and represents procurement of diagnostic testing supplies from Cepheid's established portfolio of molecular diagnostic solutions. The order was placed at Cepheid's...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $27,650.40 by the Defense Logistics Agency Medical Supply Chain on November 13, 2025. This firm fixed-price delivery order, designated XPRSMVP-10 with completion targeted for November 20, 2025, represents a procurement of diagnostic testing supplies and reagents under an existing indefinite delivery contract vehicle. The award carries no set-aside designation,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,259.80 by the Defense Logistics Agency Medical Supply Chain on November 10, 2025, with an ultimate completion date of November 18, 2025. This firm fixed-price delivery order, issued under contract number GXGBSLBXC-10, carries no set-aside designation and represents a continuation of Cepheid's established role as a primary federal supplier of diagnostic...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order (XPRSMVP-10) valued at $2,304.20 under a Defense Logistics Agency Medical Supply Chain Indefinite Delivery Contract. This firm fixed-price delivery order, issued on November 12, 2025, with an ultimate completion date of November 19, 2025, involves the supply of molecular diagnostic products, consistent with Cepheid's core business of providing advanced diagnostic solutions. The contract carries no set-aside...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,395.95 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025, with an ultimate completion date of October 27, 2025. This firm fixed-price delivery order, designated 4569773284 under the contract vehicle GXCT/NG-10, represents work to be performed at Cepheid's Sunnyvale facility. The award carries no set-aside designation, reflecting Cepheid's competitive positioning as an...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $4,447.49 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 11, 2025. This delivery order carries no set-aside designation and will be performed in Sunnyvale, California. The award represents a continuation of Cepheid's established relationship with federal healthcare and defense...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems and reagents, was awarded a firm fixed-price delivery order valued at $2,395.95 by the Defense Logistics Agency Medical Supply Chain on November 6, 2025, with an ultimate completion date of November 14, 2025. This delivery order carries no set-aside designation and represents a continuation of Cepheid's extensive role as a primary federal supplier of diagnostic solutions, particularly for infectious...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $13,096.80 by the Defense Logistics Agency Medical Supply Chain on November 7, 2025, with an ultimate completion date of November 24, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is structured as a firm fixed-price contract with no set-aside designation and relates to molecular diagnostic testing supplies, specifically reagent cartridges and test kits for detecting COVID-19, influenza, and...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F105GDelivery Order
Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,382.52 by the Defense Logistics Agency Medical Supply Chain on November 12, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price delivery order, designated XPRSMVP-10, carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. As a leading federal supplier of advanced molecular diagnostic systems and reagents, Cepheid has established substantial capability in providing diagnostic solutions across multiple federal healthcare agencies, including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and the U.S. Coast Guard. The delivery order falls under Cepheid's existing contracting relationships with the Defense Logistics Agency Medical Supply Chain, which has previously issued numerous orders for diagnostic testing supplies, test kits, and reagents supporting federal healthcare operations. Cepheid's federal portfolio demonstrates extensive experience delivering molecular diagnostic products and services, including GeneXpert diagnostic systems, PCR test kits, and maintenance services for infectious disease detection. The company's firm fixed-price contracting structure and competitive positioning reflect its role as a primary federal supplier of rapid molecular diagnostic testing capabilities for conditions including COVID-19, influenza, respiratory syncytial virus, and other infectious diseases critical to military and federal healthcare missions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 11/12/25 |